E
Eric C. Seaberg
Researcher at Johns Hopkins University
Publications - 131
Citations - 9057
Eric C. Seaberg is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Multicenter AIDS Cohort Study & Hepatitis C. The author has an hindex of 46, co-authored 123 publications receiving 8487 citations. Previous affiliations of Eric C. Seaberg include University of Pittsburgh & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Chloe L. Thio,Eric C. Seaberg,Richard L. Skolasky,John P. Phair,Barbara R. Visscher,Alvaro Muñoz,David L. Thomas +6 more
TL;DR: Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected withAIDS.
Journal ArticleDOI
Predictors of patient and graft survival following liver transplantation for hepatitis C
Michael Charlton,Eric C. Seaberg,Russell H. Wiesner,James E. Everhart,Rowen K. Zetterman,John R. Lake,Katherine M. Detre,Jay H. Hoofnagle +7 more
TL;DR: While long‐term patient and graft survival following liver transplantation for end‐stage liver disease secondary to HCV are generally comparable with that of most other indications, higher pretransplantationHCV‐RNA titers are strongly associated with poor survival among HCV‐infected recipients.
Journal ArticleDOI
Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome
Russell H. Wiesner,A. Jake Demetris,Steven H. Belle,Eric C. Seaberg,John R. Lake,Rowen K. Zetterman,James E. Everhart,Katherine M. Detre +7 more
TL;DR: The histological severity of rejection was an important prognosticator: the use of antilymphocyte preparations was higher, and the time to death or retransplantation was shorter, for patients with severe rejection, calling into question whether complete elimination of all rejection or alloreactivity is a desirable goal in liver transplantation.
Journal ArticleDOI
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
Rolland C. Dickson,JE Everhart,John R. Lake,Y Wei,Eric C. Seaberg,RH Wiesner,RK Zetterman,Timothy L. Pruett,Michael B. Ishitani,Jay H. Hoofnagle +9 more
TL;DR: De novo posttransplantation hepatitis B infection occurs at a high rate in recipients of donors with anti-HBc, suggesting that the virus may persist in the liver despite serological resolution of infection.
Journal ArticleDOI
Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance
Juliette Morgan,Martin I. Meltzer,Brian D. Plikaytis,Andre N. Sofair,Sharon Huie-White,Steven Wilcox,Lee H. Harrison,Eric C. Seaberg,Rana A. Hajjeh,Steven M. Teutsch +9 more
TL;DR: The findings underscore the burden of candidemia, particularly regarding the risk of death, length of hospitalization, and cost associated with treatment (Infect Control Hosp Epidemiol 2005;26:540-547).